🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

150,36 USD

Máx. histórico

156,45

71 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-3,89%

Rango 52 semanas

82,91 – 156,92

Variación hoy

+3,93%

Cierre anterior

144,67

Rango de hoy

146,05 – 150,40

Volumen hoy

10.698.412

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
155,01 (puede no estar actualizado)
Dividend yield
2,35% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 día
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,26%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
27/10/2021 82,48 82,48 81,30 81,54 -0,86% 1,43% 8.465.400
26/10/2021 81,90 82,36 81,71 82,25 +0,72% 0,79% 9.352.500
25/10/2021 81,03 81,72 79,95 81,66 +0,63% 2,18% 9.365.900
22/10/2021 81,15 81,48 80,88 81,15 -0,02% 0,74% 7.543.600
21/10/2021 81,11 81,26 80,28 81,17 +0,12% 1,21% 9.893.600
20/10/2021 79,32 81,25 79,31 81,07 +1,99% 2,45% 11.465.500
19/10/2021 78,73 79,52 78,11 79,49 +3,03% 1,79% 15.577.100
18/10/2021 78,74 78,74 77,11 77,15 -1,51% 2,07% 13.075.500
15/10/2021 78,20 79,06 77,98 78,33 +0,00% 1,38% 12.866.800
14/10/2021 78,97 79,67 77,98 78,33 -0,79% 2,14% 14.607.900
13/10/2021 79,59 79,66 78,78 78,95 -0,80% 1,11% 9.462.600
12/10/2021 80,18 80,18 79,25 79,59 -0,43% 1,16% 10.945.000
11/10/2021 81,64 81,64 79,87 79,93 -0,87% 2,17% 11.279.700
08/10/2021 81,67 81,80 80,53 80,63 -1,60% 1,56% 12.121.100
07/10/2021 81,54 82,67 81,03 81,94 +1,59% 2,01% 14.190.500
06/10/2021 81,50 81,68 80,15 80,66 -1,15% 1,88% 17.608.000
05/10/2021 82,78 83,39 81,30 81,60 -1,81% 2,52% 28.977.800
04/10/2021 84,17 84,56 82,42 83,10 +2,09% 2,54% 53.553.300
01/10/2021 81,56 84,34 80,63 81,40 +8,37% 4,55% 102.497.300
30/09/2021 75,58 76,65 75,10 75,11 +0,03% 2,05% 16.248.600
29/09/2021 73,61 75,70 73,58 75,09 +2,41% 2,88% 16.054.500
28/09/2021 73,55 73,82 72,66 73,32 -0,05% 1,58% 11.836.200
27/09/2021 73,51 74,27 73,34 73,36 -0,34% 1,27% 8.630.600
24/09/2021 73,59 74,63 73,35 73,61 +0,77% 1,74% 14.714.700
23/09/2021 72,68 74,04 72,57 73,05 +1,40% 2,02% 12.813.500
22/09/2021 72,33 72,41 71,86 72,04 +0,10% 0,76% 9.028.700
21/09/2021 72,48 72,68 71,77 71,97 +0,06% 1,26% 11.995.900
20/09/2021 71,16 72,61 71,12 71,93 +0,35% 2,09% 15.989.400
17/09/2021 71,19 72,00 70,89 71,68 -0,40% 1,56% 43.406.600
16/09/2021 73,02 73,02 71,69 71,97 -1,15% 1,82% 14.818.900